Status:
COMPLETED
Study of Proteins in Head and Neck Cancer Cells
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
Up to 120 years
Brief Summary
RATIONALE: Studying proteins in head and neck cancer cells in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This labor...
Detailed Description
OBJECTIVES: * Define the function and mechanism of LZAP in regulating ARF. * Determine the mechanism and biological consequences of LZAP inhibition of NF-κB. * Determine if LZAP has tumor suppressor ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Head and neck cancer tumor cell line
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00896948
Start Date
May 1 2005
Last Update
March 14 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States, 37064
2
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, United States, 37064
3
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232-6838